Mathieu Leclerc
1Patents
0h-index
4Co-inventors
19Inventor score
Filing activity: Jun 22, 2017 → Jun 22, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11359027B2 | Prevention or treatment of hematologic malignancy relapse using a TNFR2 antagonist | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.